FDA Clearance Tracker · P190018-S051
Clareon Aspheric Hydrophobic Acrylic Intraocular Lens with the AutonoMe Pre- Loaded Delivery System, Clareon Toric Asphe
Last checked: Nov 20, 2026Latest source record: Aug 17, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Aug 17, 2026
Approved
Time to decision
88 days
Received May 21, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P190018-S051
- Device name
- Clareon Aspheric Hydrophobic Acrylic Intraocular Lens with the AutonoMe Pre- Loaded Delivery System, Clareon Toric Asphe
- Applicant
- Alcon Laboratories, LLC
- Applicant location
- Fort Worth, TX
- Received
- May 21, 2026
- Decided
- Aug 17, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P190018
Device type
- Device type
- intraocular lens (HQL)
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
approval for a new packaging configuration, automation of the primary and secondary packaging processes, and updates to shelf-life and storage conditions of the Clareon IOLs (to extend the shelf life from three (3) and four (4) years to five (5) years at the temperature of 30 °C) at the Cork, Ireland manufacturing facility
Source documents
Other decisions for Alcon Laboratories, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P190018 · Decided Jan 7, 2020 · 180 days after receipt
Device type: intraocular lens (HQL) · Ophthalmology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.